Connect with us

Hi, what are you looking for?

Economy

Israel, NZ give interim approval for sale of virus nasal spray firm, company says

JERUSALEM/WELLINGTON — Israel and New Zealand have given interim approval for the sale of biotech firm SaNOtize Research and Development’s Nitric Oxide Nasal Spray (NONS) which could help prevent transmission of coronavirus disease 2019 (COVID-19), the company said on Monday.

Manufacturing of NONS, under the brand name Enovid, has begun in Israel with SaNOtize’s partner Nextar Chempharma Solutions Ltd. and it is expected to be on sale there this summer.

In New Zealand, SaNOtize has registered its nasal spray with the New Zealand Medicines and Medical Devices Safety Authority, which permits the company to distribute and sell NONS over the counter immediately, the Vancouver-based company said.

However, New Zealand’s health ministry said it has not approved the product for use as an anti-viral nasal spray.

The approval referred to by the company may relate to a notification made to the New Zealand Web-Assisted Notification Database (WAND) operated by Medsafe, where medical devices for supply in New Zealand are required to be notified. This is not an application or approval process, the health ministry said in a statement on Tuesday.

“The presence of an entry on this database does not confirm or imply that the product meets the requirements of the Medicines Act 1981,” it said in a statement, adding that it would follow up with the company.

Last week, SaNOtize and Ashford and St. Peter’s Hospitals NHS Foundation Trust in Surrey, UK, announced results of clinical trials showing that NONS was an effective antiviral treatment that could prevent the transmission of COVID-19, shorten its course, and reduce the severity of symptoms and damage in those already infected.

Chris Miller, SaNOtize’s chief science officer, said its formulation of Nitric Oxide for use in humans is designed to “kill viruses in the upper airways, preventing them from incubating and spreading to the lungs.” — Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Investing

Lloyd’s of London could leave its iconic City of London headquarters after four decades in one of the most consequential signs yet of how...

Investing

As we enter a new year, I want to talk about the importance of balance, perspective, support and productivity and I’m here to make...

Investing

London-based edtech company MyTutor has acquired Fire Tech, a training platform that teaches children technology skills such as coding. The acquisition will see MyTutor...

Investing

British autonomous vehicle startup Wayve has raised $200m (£147m) in a funding round backed by Microsoft and Virgin. The London-based firm will use the...

Investing

London-based contract automation platform Juro has raised $23m (£16.9m) in a Series B funding round. The funding was led by Eight Roads, a global...

Investing

To sustain business growth, it’s crucial to create key business opportunities. Don’t be so busy in your day-to-day that you miss them … Faced...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.